Lastly, female AIS patients have been shown to have lower androgen levels than age-matched controls, and further in vitro experiments suggested that this promoted abnormal cartilage development, possibly via the AR/IL-6/STAT3 signalling pathway (Wu et al., 2021). The gene discussed is IL6; the disease is androgen insensitivity syndrome.